Gary Kupfer MD
Professor of Pediatrics (Hematology / Oncology) and of Pathology; Clinical Program Leader, Pediatric Hematology & Oncology Program, Smilow Cancer Hospital; Section Chief, Pediatric Hematology/Oncology; Clinical Research Program Leader, Pediatric Hematology & Oncology Program, Yale Cancer Center
Departments & Organizations
Yale Combined Program in the Biological and Biomedical Sciences (BBS): Molecular Cell Biology, Genetics and Development | Molecular Medicine, Pharmacology, and Physiology
Stem Cell Center, Yale: Stem Cell Self-Renewal and Cell Symmetry
Cancer Center, Yale: Pediatric Hematology & Oncology Program | Radiobiology & Radiotherapy
Pediatrics: Pediatric Hematology & Oncology | Kupfer Lab
Genomic instability; Development of cancer; Genetic syndrome Fanconi anemia (FA); Viral protein enhancement of cancer therapeutics more...
- B.S., University of Florida, 1983
- M.D., Johns Hopkins University School of Medicine, 1989
- Mi J, Kupfer GM. (2005). The Fanconi anemia core complex associates with chromatin during S phase. Blood 105(2):759-66.
- Mihaylova V, Green A, Khurgel M, Semmes OJ, Kupfer GM. (2008) Human T Cell Leukemia Virus I Tax1 Protein Sensitizes p53 Mutant Cells to DNA Damage. Cancer Research, in press.